Trial Profile
A phase I pharmacokinetic interactions trial of doravirine and dolutegravir in healthy adults
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Oct 2016
Price :
$35
*
At a glance
- Drugs Dolutegravir (Primary) ; Doravirine (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors Merck & Co
- 29 Oct 2016 New trial record
- 04 Oct 2016 Results published in the Clinical Pharmacokinetics.